Abstract
The oral delivery of allergen genes in chitosan particles may protect against allergy and anaphylaxis (pages 387–391).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Roy, K., Mao, H.Q., Huang, S.K. & Leong, K.W. Oral gene delivery with chitosan-DNA nanoparticles generate immunologic protection in a murine model of peanut allergy. Nature Med. 5, 387–391 (1999).
Bousquet, J., Lockey, R.F. & Malling, H.J. eds. WHO Position Paper: Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 53, (suppl. 44) 1–42 (1998).
Durham, S.R. & Till, S.J. Immunologic changes associated with allergen immunotherapy. J. Allergy Clin. Immunol. 102 , 157–164 (1998).
Holt, P.G. Immunoregulation of the allergic reaction in the respiratory tract. Eur. Respir. J. 22, 85s–89s (1996).
Holt, P.G., O'Keeffe, P., Holt, B.J., Upham, J.W., Baron-Hay, M.J., Suphioglu, C., Knox, B., Stewart, G.A., Thomas, W.R. & Sly, P.D. T-cell "priming" against environmental allergens in human neonates: sequential deletion of food antigen reactivity during infancy with concomitant expansion of responses to ubiquitous inhalant allergens. Pediatr. Allergy Immunol. 6, 85–90 (1995).
Clavel, R., Bousquet, J. & Andre, C. Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 53, 493– 498 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moffatt, M., Cookson, W. Gene therapy for peanut allergy. Nat Med 5, 380–381 (1999). https://doi.org/10.1038/7374
Issue Date:
DOI: https://doi.org/10.1038/7374